Clinical Trial Update: Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ga-68-CXCR4 PET/CT imaging in patients with indolent B-cell non-Hodgkin lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Ga-68-CXCR4 (Gallium-68 CXCR4 radiotracer)

Snippet

Sponsor: Koo Foundation Sun Yat-Sen Cancer Center | Conditions: Indolent B-Cell Non-Hodgkin Lymphoma | Phase 2 | Status: RECRUITING